8 stories
The intense demand for revolutionary weight loss drugs like Ozempic and Wegovy has inadvertently birthed a dangerous shadow industry. As legitimate supplies dwindle, desperate individuals are falling...
Weight-loss injections have dominated health headlines, but new research suggests their effectiveness isn't one-size-fits-all. We break down the latest findings on how these medications impact differe...
A recent File on 4 investigation dives deep into the meteoric rise of weight loss injections, uncovering the health risks and systemic pressures lurking behind the miracle headlines. From supply short...
The US weight-loss drug market has exploded, igniting an intense rivalry between pharmaceutical giants. This battle isn't just about market share; it's about reshaping public health and access to grou...
England's Chief Medical Officer warns that while new weight-loss medications are powerful tools, relying on them to solve the obesity crisis ignores the root causes of a broken food environment.
The battle for supremacy in the booming weight-loss drug market has intensified, as Novo Nordisk, the maker of the blockbuster drug Wegovy, has launched a lawsuit against a rival. The pharmaceutical g...
Pharmaceutical giant Novo Nordisk is set to debut a significant commercial for its weight-loss drug, Wegovy, during the Super Bowl, aiming to reach millions of viewers. This high-profile advertisement...
A surge in gallbladder removals is prompting concern among medical professionals, with some suggesting a potential connection to the rising popularity of weight-loss injections like Ozempic and Wegovy...
